Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old

NCT00464672 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1893
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis

Collaborators